Dong-A targets W800 billion sales
Published: 2009-03-16 06:58:00
Updated: 2009-03-16 06:58:00
Backed by active promotion of flagship products (e.g., Stillen, Zydena) and strenuous overseas expansion, Dong-A Pharm has set an ambitious goal of 800 billion won in sales and 100 billion in operating income this year.
The local top drugmaker said that the goal represents an 14 percent rise f...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
